E. Maffioletti

发表

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response.

M. Bortolomasi, A. Minelli, S. Ulivi, 2020, Drug development research.

Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum.

L. Bocchio-Chiavetto, M. Gennarelli, R. Zanardini, 2014, BioTechniques.

Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy

M. Bortolomasi, M. Giacopuzzi, A. Minelli, 2014, Acta psychiatrica Scandinavica.

Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future

B. Baune, M. Bortolomasi, A. Minelli, 2021, Brain sciences.

Non-CG methylation and multiple histone profiles associate child abuse with immune and small GTPase dysregulation

T. Pastinen, T. Kwan, G. Turecki, 2021, Nature Communications.

Non-CG methylation and multiple epigenetic layers associate child abuse with immune and small GTPase dysregulation

T. Pastinen, T. Kwan, G. Turecki, 2020 .

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders

L. Bocchio-Chiavetto, M. Gennarelli, D. Tardito, 2014, Front. Cell. Neurosci..

Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes

L. Bocchio-Chiavetto, M. Gennarelli, A. Salvi, 2017, Molecular and Cellular Neuroscience.

Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16–20 October 2015

Christopher B. Cole, Robert M. Maier, R. Yuen, 2016, Psychiatric genetics.

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

A. Serretti, D. Mehta, B. Baune, 2022, European Neuropsychopharmacology.

M. Bortolomasi, A. Minelli, L. Bocchio-Chiavetto, 2021, European journal of psychotraumatology.

Blood microRNA changes in depressed patients during antidepressant treatment

L. Milanesi, D. Corrada, C. Giovannini, 2013, European Neuropsychopharmacology.

ROLE OF ALLELIC VARIANTS OF FK506‐BINDING PROTEIN 51 (FKBP5) GENE IN THE DEVELOPMENT OF ANXIETY DISORDERS

C. R. Cloninger, M. Bortolomasi, M. Giacopuzzi, 2013, Depression and anxiety.

Biological correlates of early life stressful events in major depressive disorder

B. Baune, A. Minelli, M. Gennarelli, 2020, Psychoneuroendocrinology.

Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders

B. Baune, M. Dierssen, D. Stacey, 2021, European Neuropsychopharmacology.

miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease

G. Frisoni, M. Marizzoni, G. Forloni, 2019, Neurobiology of Aging.

Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients

A. Minelli, A. Vita, E. Sacchetti, 2020, Drug development research.

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments

A. Minelli, M. Gennarelli, D. Tardito, 2020, Genes.

Peripheral whole blood microRNA alterations in major depression and bipolar disorder.

A. Cattaneo, G. Maina, L. Bocchio-Chiavetto, 2016, Journal of affective disorders.

Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)

A. Minelli, A. Vita, C. Magri, 2021, Trials.

Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs

L. Bocchio-Chiavetto, E. Milanesi, C. Maj, 2016, Drug development research.

miR-146a Plasma Levels Are Not Altered in Alzheimer’s Disease but Correlate With Age and Illness Severity

S. Galluzzi, C. Geroldi, O. Zanetti, 2020, Frontiers in Aging Neuroscience.

BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.

M. Bortolomasi, A. Minelli, L. Bocchio-Chiavetto, 2019, The journal of ECT.

Biological markers of sex-based differences in major depressive disorder and in antidepressant response

B. Baune, M. Bortolomasi, A. Minelli, 2023, European Neuropsychopharmacology.

Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients

T. Schulze, D. Gurwitz, N. Shomron, 2015, Journal of Molecular Neuroscience.